Clinical use of DermaBind TL/FM as a wound covering for hard-to-heal wounds of various aetiologies: a case series
These observations describe the clinical use of DermaBind as a wound covering material consistent with its homologous natural protective role. Larger, prospective studies are warranted to further investigate its clinical use. The authors would like to stress that this non-randomised, retrospective uncontrolled case series was used to describe findings, such as number of grafts applied, observed percentage of surface area reduction and graft wasted, and not to demonstrate efficacy.
Authors
- Marc Simard (ORCID: https://orcid.org/0000-0002-9424-1926)
- Sebastián Vigueras Alvarez
- Anne McMahon (ORCID: https://orcid.org/0000-0001-9657-6001)
- JOHN N. MEADORS
- D. O. Schmid
- Habeeb Yazdani
- George W. Petty
- K Hobson
- Willie E Landrum
- Ahlam Alzindani
- Oludayo Toby Ojelade
- Melissa Marballie
- Vivian Adu-Aboagye
- Georgia Chiamba
- Donovan Gowdie
Institutions
- Abbott (Sweden) (SE)
- Advisory Board Company (United States) (US)
- American Orthopaedic Foot and Ankle Society (US)
- Syneos Health (United States) (US)
- Orthopedic Foot & Ankle Center (US)
- The Centers (US)
- Science Factory (US)
- California Wellness Foundation (US)
- Doctors Hospital (US)
- Reliable System Services (United States) (US)
- Wound Care Strategies (United States) (US)
- Maxim Integrated (United Kingdom) (GB)
- EcoHealth Alliance (US)
Publication Details
- Journal
- Journal of Wound Care
- Published
- 2025-10-16
- DOI
- https://doi.org/10.12968/jowc.2025.0448
- Primary Topic
- Wound Healing and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00